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ABSTRACT 
Objective: The objective of this study was to find out the isotonicity of chloramphenicol ophthalmic in situ gel and to know the irritating effect of its 
in the eyes of test animals, so it can be to maximize absorption of the drug in the eye, minimize drug loss before corneal penetration and safe to 
used.  
Methods: This study were started by making four aseptic formulations of in situ gel preparations with a comparison of the baseline concentrations 
of different Poloxamer 407 and HPMC, F1 (5: 0.45), F2 (10: 0.45), F3 (5: 1) and F4 (10: 1). Four aseptic of in situ gel preparations, followed by a 
qualitative isotonicity test using blood cells to see the comparison between control and test preparations, and ocular irritation test using the draize 
test method to determine the presence or absence of the irritation.  
Results: The results obtained from the isotonicity test showed that the four preparations have normal blood cells that similar with isotonic control 
solution; therefore, it can be said that the preparations have been made isotonic. 
The results of the ocular irritation test using the draize test method showed for each category, such as cornea, iris, conjunctiva and edema were 
zero. A zero value on the cornea indicates no ulceration or opacity, and the iris, conjunctiva and edema were normal. Conclusion: Chloramphenicol 
in situ gel are isotonic and do not cause irritation to the rabbit's eyes, so they are safe to use and the formulation can be used for further research 
until the final goal is obtained. 
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INTRODUCTION 
Ophthalmic drug delivery system is one of the most interesting and 
challenging endeavours facing pharmaceutical scientists [1, 2]. The 
use of the new gel system, which is instilled as drops into the eye 
and undergo a sol-gel transition in the cul de sac can overcome the 
problem of poor bioavailability and therapeutic response exhibited 
by conventional ophthalmic solutions due to rapid precorneal 
elimination of the drug [2, 3]. Another advantage of in situ gel is easy 
to use, simple manufacturing at the factory, and improve both 
adherence and patient comfort by minimizing the frequency of its 
use [4]. 
Characterization of in situ gel was determined to ensure that the 
prepared preparation met the standard and it safe. Isotonicity is an 
important characteristic of the ophthalmic preparations. Isotonicity 
has to be maintained to prevent tissue damage or irritation of eye [3, 
5]. Isotonic solutions maintain the integrity of blood cells, whereas 
hypertonic shows shrinkage and hypotonic shows the bulging of cells 
[6]. Assessment of the ocular irritation potential of ophthalmic 
solutions represents an extremely important step in the development 
of both over-the-counter and prescription pharmaceuticals [7]. 
The objective of the research work was to find out the isotonicity of 
chloramphenicol in situ gel ophthalmic preparations and to know 
the irritating effect of ophthalmic gel in situ chloramphenicol gel in 
the eyes of test animals. 
MATERIALS AND METHODS 
Ethical clearance application 
Request for ethical clearance from the Health Research Ethics 
Commission, Faculty of Medicine, Universitas Padjadjaran. 
Chemicals 
The chemicals used were chloramphenicol antibiotic (Bio Basic Inc., 
Markham Ontario, Canada), hydroxypropyl methylcellulose (HPMC) 
(KERRY, Zhoucun Plant, Shandong, China), calcium chloride 
dihydrate (Merck, Indonesia), sodium chloride (NaCl) (Merck, 
Indonesia), sodium bicarbonate (Merck, Indonesia), benzalkonium 
chloride (Merck, Indonesia), poloxamer 407 (Kolliphor® P 407, 
BASF Indonesia), aqua pro injection (Ikapharmindo Putramas, 
Indonesia), 70% ethanol (Ikapharmindo Putramas, Indonesia) and 
propylenglycol (Ikapharmindo Putramas, Indonesia).  
 
Table 1: 22 factorial design optimization results of chloramphenicol ophthalmic in situ gel 
Chemicals Formulas of chloramphenicol in situ gel (% w/v) 
F1 F2 F3 F4 
Chloramphenicol 0.5 0.5 0.5 0.5 
Propylenglycol 10 10 10 10 
Poloxamer 407 5 10 5 10 
HPMC 0.45 0.45 1 1 
Benzalkonium chloride* 0.01 0.01 0.01 0.01 
Aqua pro injection q. s. 100 100 100 100 
*Amount of Benzalkonium chloride in terms of % v/v, Note: F1–F4 = Formula 1–Formula 4 
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Optimization of ophthalmic chloramphenicol in situ gel formula 
The optimization was performed on the poloxamer 407 and HPMC bases 
by using a 22 factorial design. The concentration of poloxamer 407 (X1) 
and concentration of HPMC (X2) were chosen as independent variables 
in 22 full factorial designs. The real values at the lower and upper levels 
of X1 were 5% and 10% and X2 were 0.45% and 1%. 
Formulation of ophthalmic chloramphenicol in situ gel 
The optimization of the formula was performed on poloxamer 407 and 
HPMC bases by using a 22 factorial design. Optimization with a two-level 
factorial resulted in 4 variations of the formulas, as listed in table 1. 
Table 1 showed the optimized formula for poloxamer 407 dan HPMC 
that had been added to active substance and excipients whose 
functions are known, respectively. After that, all formulas were 
made according to the procedure. After the preparations were made, 
isotonicity and irritation evaluations were carried out. 
Procedure for chloramphenicol in situ gel formulation 
The formulation process has been carried out aseptically in a laminar 
airflow (LAF) room that was sterilized with 70% alcohol. After cleaning, 
the UV lamp was turned on for 1.5 h. After that, the neon light and the 
blower were turned on. Each formula was made aseptically. The 
poloxamer 407 and HPMC bases were made by dissolving each 
substance in hot aqua dest in a separate container. The poloxamer 407 
was dissolved continuously and gradually with slow stirring to prevent 
the formation of foam. It was dissolved in an aqueous phase that has 
been heated to 70–90 °C [8]. The HPMC base was made by putting the 
required amount of hot water (approximately 70 °C) into the container. 
HPMC was added gradually and we waited for it to float on the surface of 
the water. After each polymer was dissolved, and the two polymers were 
mixed and stirred until homogeneous. The mixed base was cooled to 
support the gelling process. Then the mixed base was sterilized with an 
autoclave at 121 °C for 15 min [9]. The autoclave sterilized base was 
mixed with a mixture of chloramphenicol, propylenglycol and 
benzalkonium chloride that had been sterilized before with a bacterial 
filter (0.22 μm) until homogeneous. 
Isotonicity evaluation 
Isotonicity is an important characteristic of the ophthalmic. 
Isotonicity has to be maintained to prevent tissue damage or 
irritation of the eye. The optimized formulations were mixed with 
few drops of blood and then the shape of blood cells was observed in 
the microscope under ×45 magnifications [10-12]. The results 
obtained were compared with the control solution. Isotonic 
solutions maintain the integrity of blood cells, whereas hypertonic 
shows shrinkage and hypotonic shows the bulging of cells.  
Ocular irritancy 
The Draize technique was designed for the ocular irritation potential 
of the ophthalmic product before marketing. One hundred 
microliters of the formulation were placed into the lower cul-de-sac 
with an observation of the various criteria made at the designed 
required time interval of 1 h, 24 h, 48 h, 72 h after administration 
[12-14]. Approval of the Institutional Animal Ethics Committee was 
obtained before the commencing of the study. Ethical approval has 
been given from the Faculty of Medicine Universitas Padjadjaran 
with Number: 590/UN6. KEP/EC/2019. A total 3 albino New 
Zealand rabbits (of either gender) weighing 1.5–2 kg were used for 
the present study. Three rabbits are used for the four formulas, 
which will be given treatment, namely the preliminary test and the 
confirmation test for each formula. Prior to the test, the rabbits were 
acclimatized for 5 d with the cleaned condition and they eat 
normally, and then their eye health was confirmed. Then a 
preliminary test was carried out using one rabbit first by exposing 
the preparation to one rabbit's eye and the other eye as a negative 
control. In this preliminary test, the eyes of the rabbits were 
observed at the 1st, 24th, 48th and 72nd hours after exposure to the 
test preparation, after which confirmation tests were carried out on 
two other rabbits. These two tests were performed for all formulas. 
Retrieval of irritation data on experimental animals will be taken 
photos along with the score data adjusted to the Regulation of the 
Head of BPOM Number 7 of 2014 [15, 16]. 
The assessment of the reaction of the test preparation against the 
eye is assessed and recorded according to the score stated in the 
regulation. Assessment of eye reactions (conjunctiva, cornea, iris) 
and other injuries to the eye or systemic effects must be reported.  
The eye irritation score that should be evaluated is the degree of eye 
injury and the presence or absence of reversibility. Individual scores 
do not represent an absolute standard for the irritant properties of 
the test preparation but should be viewed as a reference value. The 
test preparation irritation score is a combination of all observations 
from the test [16-18]. 
RESULTS  
Isotonicity of in situ gel preparations 
After observing using a microscope, the results showed that the four 
preparations have given a normal blood cell that similar results with 
isotonic control solution. This can be seen in fig. 1 and 2 where 
observations were made using a isotonic control solution in the form 
of NaCl 0.9%, a hypertonic control solution in the form of NaCl 2% 
and hypotonic control solution in the form of NaCl 0.2%. Therefore it 
can be said that the preparations have been made isotonic. 
Ocular irritation test results using the draize test method 
Ocular irritation testing was carried out using rabbits that have 
received ethical approval from the Health Research Ethics 
Committee, Faculty of Medicine, Padjadjaran University with 
Number: 590/UN6. KEP/EC/2019. The degree of irritation was 
evaluated by scoring the irritation that occurs in the cornea, iris, 
conjunctiva and edema. The data can be seen in table 2. 
 
 
Fig. 1: Observation results of isotonicity test on control solution 
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Fig. 2: Observation results of isotonicity test on preparations solution 
 
Table 2: The score of irritation 
 Rabbit 1 (preliminary test) Rabbit 2 (a confirmation test) Rabbit 3 (a confirmation test) 
 Cr I Cj E Cr I Cj E Cr I Cj E 
F1 0 0 0 0 0 0 0 0 0 0 0 0 
F2 0 0 0 0 0 0 0 0 0 0 0 0 
F3 0 0 0 0 0 0 0 0 0 0 0 0 
F4 0 0 0 0 0 0 0 0 0 0 0 0 
 Cr: Cornea, I: Iris, Cj: Conjunctiva, E: Edema 
 
Based on the observations made, the results obtained for each 
category, such as cornea, iris, conjunctiva and edema were zero. The 
purpose of this zero value from each category has its own 
description. A zero value on the cornea indicates no ulceration or 
opacity, the iris indicates normal, the conjunctiva shows normal 
blood vessels or no redness that mean normal, and the edema 
category a zero value indicates normal that there is no swelling in 
the rabbit's eye [16-18].
 
 
Fig. 3: Example image of the result of irritation test on rabbit's eye 
Kurniawansyah et al. 
Int J App Pharm, Vol 13, Issue 1, 2021, 103-107 
106 
If seen from the results listed in table 2 and fig. 3, it can be said that the 
preparations made do not cause irritation to rabbits. In the irritation 
test above, a preliminary test was carried out using a rabbit, which 
according to the Regulation of the Head of BPOM Number 7 of 2014 
the purpose of this preliminary test is to determine whether the test 
preparation is a strong irritant or not. If the preliminary test shows 
that the preparation is a strong irritant, no further testing should be 
carried out. If in the preliminary test the preparation does not indicate 
a strong irritant, a confirmation test must be carried out using two 
additional animals. In the preliminary test and confirmation test, 
observations were made at the 1st hour, 24th h, 48th h and 72th h after 
the exposure of the test preparation, after which an assessment was 
carried out with the scores shown in table 3. The extrapolation of the 
results of eye irritation testing in animals to humans can be considered 
valid because in some cases, albino rabbits are known to be more 
sensitive than humans in terms of eye irritation [17, 18].
 
Table 3: Grading of ocular lesions [18] 
Object of observation Score 
Cornea: Opacity: degree of density (readings should be taken from most dense area)  
No ulceration or opacity 0 
Scattered or diffuse areas of opacity (other than slight dulling of normal lustre); details of iris clearly visible 1 
Easily discernible translucent area; details of iris slightly obscured 2 
Nacrous area; no details of iris visible; size of pupil barely discernible 3 
Opaque cornea; iris not discernible through the opacity 4 
Maximum possible: 4  
Iris   
Normal  0 
Markedly deepened rugae, congestion, swelling, moderate circumcorneal hyperaemia; or injection; iris reactive to light (a sluggish 
reaction is considered to be an effect 
 
1 
Hemorrhage, gross destruction, or no reaction to light 2 
Maximum possible: 2  
Conjunctiva 
Redness (refers to palpebral and bulbar conjunctivae; excluding cornea and iris) 
Normal 0 
Some blood vessels hyperaemic (injected) 1 
Diffuse, crimson colour; individual vessels not easily discernible 2 
Diffuse beefy red 3 
Maximum possible: 3  
Chemosis/edema Swelling (refers to lids and/or nictating membranes)  
Normal 0 
Some swelling above normal 1 
Obvious swelling, with partial eversion of lids 2 
Swelling, with lids about half-closed 3 
Swelling, with lids more than half-closed 4 
Maximum possible: 4  
 
This eye irritation test aims to obtain information on the dangers 
that arise when the test preparation is exposed to the eyes and the 
mucous membranes of the eyes. In the test, a preliminary test was 
carried out with one rabbit first, then followed by a confirmation 
test with two other rabbits. 
The in situ gel preparation formulation was obtained from the 
optimization results that were carried out in previous studies using 
a two-level factorial method in the Design Expert® software. The 
formula used has the active substance chloramphenicol, which is a 
broad-spectrum antibiotic that actively works on many types of 
microbes, namely gram-positive bacteria and gram-negative 
bacteria. In a study conducted by Nayak et al., the chloramphenicol 
concentration of 0.5% in ophthalmic preparations is a concentration 
that has proven its effectiveness in the treatment of eye infections 
and chloramphenicol with a concentration of 0.5% is an eye drop 
preparation that is usually present in the market [19]. 
This formula used two bases, Poloxamer 407 and HPMC which are 
responsive to sol-to-gel phase changes. Poloxamer 407 undergoes a 
sol-to-gel phase transition due to an increase in temperature which 
causes poloxamer 407 to gradually desolvate the polymer and 
experience an increase in micelle aggregation. This process 
eventually causes the formation of micelles due to the dehydration 
process of the polyoxypropylene blocks from the poloxamer, then 
the micelles touch each other and no longer move. However, the 
mechanical strength of poloxamer is weak; therefore poloxamer is 
combined with HPMC [20, 21].  
The use of HPMC together with other polymers (in this study 
combined with poloxamer) serves to reduce the concentration of 
poloxamer so that HPMC can stabilize the concentration of 
poloxamer [21]. However, if the use of a single HPMC (without 
adding other polymers) functions as a viscosity enhancer, that can 
help control the release of preparation [22]. The advantage of the 
combined use of poloxamer 407 and HPMC bases is that this 
combination increases the viscosity of the preparation so that the 
contact time of the preparation with the eye is longer so that it can 
increase the bioavailability of the drug [21, 23].  
CONCLUSION 
All formulations of chloramphenicol in situ ophthalmic gel prepared 
showed good isotonicity that the preparations have been made 
isotonic, and did not cause irritation to the eyes of rabbits, so the 
preparation was safe to use and the formulation can be used for 
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